Fulcrum Therapeutics, Inc. ( FULC) - Stock Earnings
FULC Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -19.6 million USD | — USD |
| 2025Q4 | -20.3 million USD | — USD |
| 2026Q1 | -18.9 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
FULC Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -97.3 million USD | 2.8 million USD |
| 2024 | -9.7 million USD | 80.0 million USD |
| 2025 | -74.9 million USD | — USD |
| 2026 Est. | — | — |
FULC
Price: $3.46
52 week price:
Earnings Per Share: -1.15 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 493900
Market Capitalization: 199.7 million